Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1979-03-05
1980-05-20
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
A61K 3902
Patent
active
042039703
ABSTRACT:
A sub-cellular antigenic fraction of Bordetella bronchiseptica protects against the incidence and severity of swine atropic rhinitis.
REFERENCES:
Harris et al., Am. J. Vet. Res. 33(10):1975-1984 (1972) Immunization of Pigs against Bordetella bronchiseptica Infection by Parenteral Vaccination.
Goodnow Vet. Med. & Small Anim. Clin. 72(7):1210-1212 (1977) Control of Atrophic Rhinitis with a Bordetella bronchiseptica Bacterin.
Brandenburg Can. J. Comp. Med. 42(1):23-28 (1978) Bordetella Rhinitis in Pigs: Serum and Nasal Antibody Response to Bordetella Bacterins.
Goodnow et al. Am. J. Vet. Res. 40(1):58-60 (1979) Efficacy of Bordetella bronchiseptica Bacterin in Controlling Enzootic Atrophic Rhinitis in Swine.
Carlo Dennis J.
Hagopian Arpi
Kniskern Peter J.
Cheng Theresa Y.
Levitt Julian S.
Merck & Co. , Inc.
Perrella Donald J.
Rose Shep K.
LandOfFree
Swine atropic rhinitis vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Swine atropic rhinitis vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Swine atropic rhinitis vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-450193